SEC Company Response from Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) (CANF) — Sep 12, 2018
Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196)
Date: Sept. 12, 2018 · CIK: 0001536196 · Accession: 0001213900-18-012395
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226696
Letter
CAN-FITE BIOPHARMA LTD.
Bareket Street,
Kiryat Matalon
PO Box 7537
Petach Tikva, 4951778
Israel
September 12, 2018
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attention: Christine Westbrook
Re: Can-Fite BioPharma Ltd.
Registration Statement on Form F-1/A Filed August 31, 2018
File No. 333-226696
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on September 13, 2018, or as soon thereafter as possible.
The Company hereby acknowledges the following:
• should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
• the Company may not assert staff comments and the declaration of effectiveness of this Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
CAN-FITE BIOPHARMA LTD.
By: /s/ Pnina Fishman
Name: Pnina Fishman
Title: Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
CAN-FITE
BIOPHARMA LTD.
10
Bareket Street,
Kiryat
Matalon
PO
Box 7537
Petach
Tikva, 4951778
Israel
September 12, 2018
VIA
EDGAR
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Christine Westbrook
Re:
Can-Fite
BioPharma Ltd.
Registration
Statement on Form F-1/A Filed August 31, 2018
File
No. 333-226696
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become
effective at 4:00 p.m., Eastern Time, on September 13, 2018, or as soon thereafter as possible.
The
Company hereby acknowledges the following:
• should
the Securities and Exchange Commission (the “Commission”) or the staff, acting
pursuant to delegated authority, declare the Registration Statement effective, it does
not foreclose the Commission from taking any action with respect to the Registration
Statement;
• the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the Registration Statement effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the Registration Statement; and
• the
Company may not assert staff comments and the declaration of effectiveness of this Registration
Statement as a defense in any proceeding initiated by the Commission or any person under
the federal securities laws of the United States.
CAN-FITE
BIOPHARMA LTD.
By:
/s/
Pnina Fishman
Name:
Pnina Fishman
Title:
Chief Executive Officer